Cell line · CVCL_1107
Papers113
1 to 20 of 113
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Capsaicin suppresses metastasis in tongue squamous cell carcinoma by reversing epithelial-mesenchymal transition via the AMPK/HIF-1α/Claudin-1 axis | Biol Direct | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dual targeting of ACSS2 and ACLY by a novel inhibitor S8588 suppresses oncogenic lipogenesis and overcomes metabolic compensation in oral squamous cell carcinoma. | Int J Oral Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Aberrant Accumulation of Cyclin D1 Rewires Glutamine Metabolism and Generates a Metabolic Vulnerability in Squamous Cell Carcinoma. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| NLRX1 contributes to immunotherapeutic resistance of head and neck squamous cell carcinoma by suppressing type I interferon pathway. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Genome-wide CRISPR screen identifies AMBRA1 as a potential biomarker of response to platinum-based therapies in oral squamous cell carcinomas. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor-Resistant Head and Neck Squamous Cell Carcinoma. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Serum metabolomics profiling in head and neck squamous cell carcinoma: a multicentre diagnostic study. | EBioMedicine | 2026 | Its Methods give the RRID and name the line | PubMed | |
| SLC15A4 promotes oral cancer progression by regulating TLR9 and activating the JAK/STAT signaling pathway. | Head Face Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Maackia amurensis seed lectin inhibits oral squamous cell carcinoma tumorigenesis by suppressing N6-methyladenosine modification-mediated SRY-box transcription factor 2 expression. | J Int Med Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Stiffness-related stress granules promote the metastasis of early-stage oral squamous cell carcinoma via anoikis resistance. | Cell Oncol (Dordr) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TRAPPC4 Promotes GPX4 Stability to Drive Ferroptosis Resistance and Tumor Progression in Head and Neck Squamous Cell Carcinoma. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Loss of Gαq reshapes fibroblast traits and drives tumor-stroma remodeling in oral cancer progression. | EMBO Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CCL26-Mediated Modulation of Endothelial Secretome by Hypoxia-Induced Tumor-Derived Exosomes Enhances Metastatic Progression in Head and Neck Cancer. | Head Neck | 2026 | Its Methods give the RRID and name the line | PubMed | |
| An exosome-biomimetic photothermal nanocarrier for IGF2BP2 siRNA delivery and enhanced ferroptosis in head and neck squamous cell carcinoma. | Mater Today Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Astragaloside IV represses the immune evasion and acidic microenvironment of oral squamous cell carcinoma. | Cell Mol Biol Lett | 2026 | Its Methods give the RRID and name the line | PubMed | |
| pH/ROS-Responsive Injectable Hydrogel Co-Loaded with B7-H3 Blocker and NETs Suppressor Boosts OSCC Synergistic Immunotherapy. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Loss of JAK1 Function Causes G2-M Cell-Cycle Defects Vulnerable to KIF18A Inhibition. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cascade Therapy of Periodontitis via Sequential Release of Ribosome-Targeting Antimicrobial Peptide and Irisin From a Multifunctional MOF-Based System. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| NN-01-195, a Novel Conjugate of HSP90 and AURKA Inhibitors, Effectively Targets Solid Tumors. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Genome-wide CRISPR Screening Reveals a PKA-Driven Resistance Mechanism to Metformin for Oral Cancer Prevention That Can Be Exploited by Combination with NSAIDs. | Cancer Prev Res (Phila) | 2026 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1107/papers